We are live on ! Find out more
FCM

Farallon Capital Management Portfolio holdings

AUM $17.5B
1-Year Est. Return 50.95%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+50.95%
3 Year Est. Return
+148.38%
5 Year Est. Return
+206.05%
10 Year Est. Return
+1,475.31%
AUM
$16.9B
AUM Growth
-$1.28B
Cap. Flow
-$3.58B
Cap. Flow %
-21.13%
Top 10 Hldgs %
34.65%
Holding
323
New
13
Increased
38
Reduced
39
Closed
80

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$358M
2
CRM icon
Salesforce
CRM
+$251M
3
BABA icon
Alibaba
BABA
+$173M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$159M
5
SPGI icon
S&P Global
SPGI
+$119M

Top Sells

Rank Stock Value
1
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$497M
2
TWTR
Twitter, Inc.
TWTR
+$340M
3
ZEN
ZENDESK INC
ZEN
+$296M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$294M
5
META icon
Meta Platforms (Facebook)
META
+$245M

Sector Composition

Rank Sector Weight
1 Healthcare 32.5%
2 Technology 18.76%
3 Financials 14.5%
4 Industrials 8.33%
5 Communication Services 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSEM icon
51
Tower Semiconductor
TSEM
$28.5B
$69.8M 0.41%
1,615,000
+600,000
+59% +$26.1M
CVS icon
52
CVS Health
CVS
$122B
$64.7M 0.38%
694,259
-562,000
-45% -$54.2M
INSP icon
53
Inspire Medical Systems
INSP
$1.74B
$61.1M 0.36%
242,596
-239,400
-50% -$51M
SIMO icon
54
Silicon Motion
SIMO
$8.68B
$60.5M 0.36%
931,510
– –
BRKR icon
55
Bruker
BRKR
$8.14B
$58.7M 0.35%
859,300
-84,500
-9% -$5.37M
AGIO icon
56
Agios Pharmaceuticals
AGIO
$1.93B
$56.9M 0.34%
2,025,829
+529,000
+35% +$14.9M
MDGL icon
57
Madrigal Pharmaceuticals
MDGL
$11.8B
$44.4M 0.26%
+153,000
New +$15M
RVMD icon
58
Revolution Medicines
RVMD
$44B
$40.4M 0.24%
1,698,015
-801,985
-32% -$17.1M
PTGX icon
59
Protagonist Therapeutics
PTGX
$9.44B
$39.8M 0.24%
3,651,887
– –
LEGN icon
60
Legend Biotech
LEGN
$4.01B
$37.3M 0.22%
746,614
+508,900
+214% +$24.7M
JAZZ icon
61
Jazz Pharmaceuticals
JAZZ
$16.7B
$36.6M 0.22%
229,800
-307,700
-57% -$45.1M
PACB icon
62
Pacific Biosciences
PACB
$368M
$32.8M 0.19%
+4,004,400
New +$34.5M
ISEE
63
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$31.3M 0.18%
1,462,000
+145,000
+11% +$3.09M
ALNY icon
64
Alnylam Pharmaceuticals
ALNY
$29.3B
$30.9M 0.18%
130,056
-298,400
-70% -$63.6M
KVSC
65
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$28M 0.17%
2,809,000
– –
BACA
66
DELISTED
Berenson Acquisition Corp. I
BACA
$25.1M 0.15%
2,475,000
– –
MTAL
67
DELISTED
Metals Acquisition
MTAL
$24.9M 0.15%
2,489,700
– –
APLS
68
DELISTED
Apellis Pharmaceuticals
APLS
$23.3M 0.14%
450,400
-27,600
-6% -$1.46M
TVRD
69
Tvardi Therapeutics
TVRD
$23.4M
$22.3M 0.13%
57,617
-11,827
-17% -$4.49M
BNTX icon
70
BioNTech
BNTX
$23.5B
$21M 0.12%
+140,000
New +$21.5M
IVCP
71
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$20.1M 0.12%
1,980,000
– –
LUNR icon
72
Intuitive Machines
LUNR
$2.63B
$19M 0.11%
1,900,000
– –
SEDA
73
DELISTED
SDCL EDGE Acquisition Corporation
SEDA
$17.4M 0.1%
1,732,500
– –
BRMK
74
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$17.3M 0.1%
4,850,000
– –
VAQC
75
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
$17.2M 0.1%
1,700,000
– –
1 2
3
4 5

Similar funds

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
ASRS
Arizona State Retirement System Phoenix, Arizona $17.1B AUM 30.52% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
VMPIC
Varma Mutual Pension Insurance Co Helsinki, Finland $17B AUM 24.09% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Farallon Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Farallon Capital Management held 323 positions worth $16.9B, down 7% from $18.2B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Farallon Capital Management withdrew a net $3.58B in Q4 2022, closing 80 positions and reducing 39 holdings. Its most notable exit was Change Healthcare Inc. Common Stock, an estimated $497M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Financials.

Against the trend, Farallon Capital Management opened a new position in Intuit worth $351M.

  • Farallon Capital Management's largest Q4 2022 buy was Intuit: 902,100 shares worth $351M.
  • Farallon Capital Management added most to Salesforce in Q4 2022, an estimated $251M increase.
  • Farallon Capital Management's biggest Q4 2022 reduction was Clarivate, cutting an estimated $238M.
  • Farallon Capital Management fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $497M.
  • Farallon Capital Management's ten largest holdings make up 35% of its $16.9B portfolio in Q4 2022.
  • Farallon Capital Management opened 13 new positions and closed 80 in Q4 2022.
  • Farallon Capital Management's portfolio value fell 7% quarter-over-quarter to $16.9B.

Based on Farallon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.